CNB Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Sell |
1,042
-771
| -43% | -$117K | 0.07% | 156 |
|
|
2025
Q1 | $273K | Sell |
1,813
-649
| -26% | -$97.7K | 0.14% | 128 |
|
|
2024
Q4 | $454K | Sell |
2,462
-240
| -9% | -$44.3K | 0.21% | 107 |
|
|
2024
Q3 | $532K | Sell |
2,702
-153
| -5% | -$30.1K | 0.25% | 99 |
|
|
2024
Q2 | $590K | Sell |
2,855
-123
| -4% | -$25.4K | 0.28% | 89 |
|
|
2024
Q1 | $807K | Buy |
2,978
+16
| +0.5% | +$4.34K | 0.39% | 75 |
|
|
2023
Q4 | $700K | Buy |
2,962
+263
| +10% | +$62.2K | 0.38% | 77 |
|
|
2023
Q3 | $529K | Buy |
2,699
+274
| +11% | +$53.7K | 0.31% | 87 |
|
|
2023
Q2 | $510K | Buy |
2,425
+90
| +4% | +$18.9K | 0.3% | 89 |
|
|
2023
Q1 | $471K | Buy |
2,335
+11
| +0.5% | +$2.22K | 0.29% | 90 |
|
|
2022
Q4 | $506K | Buy |
2,324
+98
| +4% | +$21.4K | 0.32% | 85 |
|
|
2022
Q3 | $438K | Buy |
2,226
+125
| +6% | +$24.6K | 0.3% | 87 |
|
|
2022
Q2 | $449K | Buy |
2,101
+146
| +7% | +$31.2K | 0.29% | 86 |
|
|
2022
Q1 | $556K | Buy |
1,955
+198
| +11% | +$56.3K | 0.31% | 84 |
|
|
2021
Q4 | $662K | Buy |
1,757
+160
| +10% | +$60.3K | 0.36% | 77 |
|
|
2021
Q3 | $660K | Buy |
1,597
+87
| +6% | +$36K | 0.4% | 72 |
|
|
2021
Q2 | $559K | Buy |
1,510
+162
| +12% | +$60K | 0.35% | 84 |
|
|
2021
Q1 | $390K | Buy |
1,348
+209
| +18% | +$60.5K | 0.27% | 91 |
|
|
2020
Q4 | $284K | Buy |
1,139
+105
| +10% | +$26.2K | 0.21% | 104 |
|
|
2020
Q3 | $234K | Sell |
1,034
-74
| -7% | -$16.7K | 0.2% | 106 |
|
|
2020
Q2 | $193K | Buy |
1,108
+54
| +5% | +$9.41K | 0.17% | 115 |
|
|
2020
Q1 | $133K | Buy |
1,054
+784
| +290% | +$98.9K | 0.14% | 145 |
|
|
2019
Q4 | $41K | Buy |
+270
| New | +$41K | 0.03% | 236 |
|